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CHAPTER I 
 
INTRODUCTION 
 
Acute myocardial infarction (MI), also known as a heart attack, afflicts about 1.5 million 
people in the United States every year and is a leading cause of mortality accounting for 1 
in every 4 deaths. MI usually results from occlusion of a coronary artery after 
atherosclerotic plaque rupture and thrombosis (Antman and Braunwald, 2001). The 
ensuing ischemia in the cardiac tissue downstream from the blocked blood vessels kills 
cardiomyocytes within minutes. The widespread cell death triggers an immediate and 
massive inflammatory response that gradually clears out cellular debris. Inflammation is 
followed by granulation tissue formation which involves the activation and proliferation 
of endothelial cells and infiltration of myofibroblasts (Frangogiannis, 2008). Endothelial 
cell proliferation and migration from existing capillary beds, also known as angiogenesis, 
leads to the formation of new vessels in an attempt to restore blood supply, whereas 
myofibroblasts deposit collagen and other extracellular matrix proteins, in order to fill in 
the wound and prevent infarct spread.  The granulation tissue eventually matures into a 
dense scar (Boudoulas and Hatzopoulos, 2009; Fig. 1.1).   
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 Figure 1.1: The Myocardial Infarction Response 
 
Although the original reaction to ischemic assault and cell death is necessary to heal the 
wound and stabilize the ventricular wall, excessive scar formation acts as a barrier to 
proper electromechanical coupling between relatively healthy regions of the heart, thus 
compromising efficient and synchronous contraction. As a result, death from MI not only 
occurs acutely, but also due to chronic complications like heart failure (Canto et al., 
2000).  
 
Current treatment alternatives for patients who suffer a myocardial infarction are limited 
to revascularization to prevent further myocyte death and medical therapy to preserve 
residual heart function and slow down ventricular remodelling and heart failure.  In the 
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last decade, there have been a number of reports in experimental models and human 
patients indicating that stem cells injected directly into the myocardium or delivered to 
the coronary circulation can improve cardiac function (Miyahara et al., 2006; reviewed 
by Boudoulas and Hatzopoulos, 2009; Schoenhard and Hatzopoulos, 2010). However, 
there seems to be limited long-term engraftment and minimal differentiation of 
transplanted stem cells into mature cardiovascular tissue (Suzuki et al., 2004; Reinecke et 
al., 2002; Kupatt et al., 2005a). 
 
Instead, the current evidence suggests that donor cells exert a favorable paracrine effect 
on the injured myocardium, preventing apoptosis and promoting healing (Heil et al., 
2004; Kupatt et al., 2005b; Gnecchi et al., 2008; Uemura et al., 2006). Some of these 
beneficial effects have been attributed to specific products of transplanted progenitor 
cells such as thymosin β4, which promotes wound healing, or the Wnt antagonist sFRP2 
(secreted frizzled-related protein 2), which protects cardiomyocytes from hypoxia-
induced apoptosis (Kupatt et al., 2005b; Gnecchi et al., 2005, Mirotsou et al., 2007; 
Hinkel et al., 2008; Alfaro et al., 2008; reviewed by Joggerst and Hatzopoulos, 2009).  
These studies suggest that it is possible to improve cardiac wound healing using various 
biological factors. Therefore, understanding the cellular and molecular regulatory 
mechanisms of innate repair may lead to new ways to improve cardiac function after MI, 
independently or in combination with stem cell therapy.   
 
A potentially important regulatory mechanism for cardiac repair is the canonical 
wnt/β−catenin signaling pathway because not only has the pathway been implicated in 
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the cardioprotective paracrine effect of post-infarction stem cell transplantation (Kupatt et 
al., 2005b; Mirotsou et al., 2006) but also, a number of studies have shown that 
endogenous wnt pathway mediators are induced after MI (Blankensteijn et al., 2000; 
Barandon et al., 2003; Chen et al., 2004; Kobayashi et al., 2009). This dissertation 
therefore focuses on the canonical wnt signaling pathway in attempts to better understand 
the molecular mechanisms controlling the intrinsic cardiac repair processes. 
 
The Wnt signaling pathway 
Signal transduction in the canonical wnt/β−catenin signaling pathway often begins with 
the binding of a wnt ligand to its corresponding frizzled receptor and LRP-5/6 coreceptor. 
This interaction, which leads to activation of disheveled (dsh), can be blocked by secreted 
frizzled-related proteins (sFRPs) and Dickkopf (dkks) proteins. Activated dsh engages a 
multi-protein degradation complex containing axin, glycogen synthase kinase-3β (GSK-
3β) and adenomatous polypopsis coli (APC). GSK-3β in the multi-protein complex 
normally phosphorylates β−catenin to cause its degradation by the proteasome, but upon 
binding of dsh, GSK-3β is inhibited, resulting in beta-catenin stabilization. Stabilized 
β−catenin accumulates in the nucleus where it binds members of the T cell factor (TCF) 
and lymphoid enhancing factor (LEF) families to cause transcription of target genes. In 
the non-canonical wnt signaling pathway, binding of wnt ligands to frizzled receptors 
trigger β−catenin-independent signaling events such as nuclear factor of activated T-cell 
(NFAT) and Janus Kinase (JNK) activation (Huelsken and Behrens 2002, Nelson and 
Nusse 2004, Moon et al 2004, Clevers 2006; Fig. 1.2). 
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 Figure 1.2: The Wnt Signaling Pathway 
 
The Wnt signaling pathway in myocardial infarction 
Multiple intermediates of the wnt signaling pathway including wnt proteins (Barandon et 
al., 2003), dsh (Chen, 2004), sFRPs (Barandon et al 2003, Kobayashi et al 2009) and 
β−catenin (Blankensteijn 2000), have been shown to be induced after MI; which suggests 
that the wnt signaling pathway may potentially be an MI therapeutic target. However, 
reports about the consequences of wnt pathway manipulation on cardiac recovery after 
MI have been somewhat contradictory.  For example, overexpression of secreted Frizzled 
Related Proteins sFRP1 and sFRP2, two antagonists of wnt signaling, resulted in 
improved cardiac function, reduced infarct size and less cardiac rupture after MI in mice, 
suggesting that blocking wnt signaling is cardioprotective (Barandon et al., 2003; 
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Mirotsou et al., 2007; Alfaro et al., 2008). Paradoxically, inactivation of sFRP2 was also 
shown to improve recovery in a mouse MI model (Kobayashi et al., 2009). Consistent 
with this last outcome, adenovirus-mediated transfer of constitutively active β−catenin, 
the primary canonical wnt pathway activator, in a rat MI model, resulted in a reduction in 
myocardial infarct size and improved wound healing, suggesting that activating canonical 
wnt signaling helps cardiac recovery (Hahn et al., 2006). 
 
These apparently conflicting results may be due to variations between animal models, 
differential regulation of canonical vs. non-canonical wnt pathway and downstream gene 
targets by specific modulators, or involvement of wnt intermediates in processes 
independent of their typical wnt signaling roles. For instance, sFRPs have been shown to 
be involved in collagen processing (Kobayashi et al., 2009). It is also possible that gain 
and loss of function approaches differentially trigger competing molecules such as the 
retinoic acid receptor, which has been shown to prevent stabilized β−catenin from 
interacting with TCF/LEF factors and activating transcription of target genes (Easwaran 
et al., 1999; Xiao et al., 2003). Finally, the cell-specificity and timing of wnt pathway 
activation or suppression likely plays a cell type- and phase-dependent role in the 
myocardial infarction response, comparable to its described stage-specific roles in heart 
development (Ueno et al., 2007; reviewed by Aisagbonhi and Hatzopoulos, 2010).  
 
Therefore, to clearly establish whether the canonical wnt/β−catenin signaling pathway 
should be targeted for MI therapies, it is important to know if the induction of various 
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wnt pathway mediators after MI results in a net activation of canonical wnt signaling, and 
in what phase of the MI response canonical wnt induction occurs.  
 
Specific Aims 
This dissertation project was aimed at investigating the role the canonical wnt signaling 
pathway plays in the myocardial infarction response. To this end, we embarked on a 
detailed analysis of canonical wnt/β−catenin signaling activity in the healthy adult mouse 
heart and in the adult mouse heart at defined phases of the inherent myocardial infarction 
response process. We reasoned that answering questions about whether the canonical wnt 
pathway is induced after MI, at which stage of the infarction response induction occurs 
and in which cell types, will give clues into the post-MI function of canonical wnt 
signaling. Such an analysis will help determine whether the canonical wnt pathway 
should be therapeutically modulated post-MI and at what wound healing stage such 
interventions should occur.  
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CHAPTER II 
 
THE CANONICAL WNT SIGNALING PATHWAY IS ACTIVATED AFTER 
MYOCARDIAL INFARCTION 
 
 
Introduction 
Wnt pathway intermediates have been shown to be increased after myocardial infarction 
in rat (Hahn et al., 2006), mouse (Blankensteijn et al., 2000; Barandon et al., 2003; Chen 
et al., 2004; Kobayashi et al., 2008) and even human (Castrillón et al., 2009). However, 
the simultaneous induction of wnt ligands known to activate canonical and non-canonical 
branches of wnt signaling, as well as the increase in the expression levels of canonical 
wnt pathway antagonists such as sFRP2, make it difficult to predict whether canonical 
wnt activity is induced overall, if activity is confined in specialized areas, or associated 
with specific cardiac tissue repair processes.  To distinguish between these possibilities, 
the global response of wnt pathway mediators to myocardial infarction was first 
evaluated. Then, the transgenic mouse line, TOPGAL, which carries the β-galactosidase 
reporter under the control of a canonical wnt pathway activated promoter that consists of 
three β−catenin responsive LEF/TCF-binding sites upstream of a minimal c-fos gene 
promoter (DasGupta and Fuchs, 1999), was used to definitively analyze the cardiac 
regions and cell populations that engage in canonical wnt signaling at baseline, in the 
healthy adult mouse heart, and after MI.  
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Results 
Expression of Wnt pathway mediators is induced after experimental myocardial 
infarction 
 
To evaluate the response of wnt pathway components to myocardial ischemic injury, and 
validate published reports, experimental myocardial infarction was induced by occluding 
the Left Anterior Descending (LAD) coronary arteries of C57BL/6J mice. Sham-operated 
mice that underwent the same surgical procedure without arterial ligation served as 
controls. 
 
Analysis for the expression of the entire set of nineteen wnt ligands, as well as three of 
Dickkopf (Dkk) family of canonical wnt signaling mediators, using conventional and 
real-time quantitative RT-PCR analysis, revealed that a number of Wnt ligands are 
expressed in normal heart including Wnt-2, Wnt-5a, Wnt-5b, Wnt-7b, Wnt-9a and Wnt-
11 (Fig. 2.1). Following experimental myocardial infarction, there is a strong 
upregulation in the transcript levels of both wnt ligands and members of the Dkk family 
(Fig. 2.1).  Specifically, by quantitative analysis we observed an induction of Wnt-2 (11-
fold), Wnt-4 (18-fold), Wnt-10b, (6-fold), Wnt-11 (3-fold), Dkk-1 (11-fold) and Dkk-2 
(6-fold) (Fig. 2.2). 
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Gene Sham 5d post-MI Gene Sham 5d post-MI
Dkk-1 Wnt-5b
Dkk-2 Wnt-6
Dkk-3 Wnt-7a
Wnt-1 Wnt-7b
Wnt-2 Wnt-8a
Wnt-2b Wnt-9a
Wnt-3 Wnt-9b
Wnt-3a Wnt-10a
Wnt-4 Wnt-10b
Wnt-5a Wnt-11
Figure 2.1: Wnt pathway intermediates are increased after myocardial infarction. RT- 
PCR was performed on RNA isolated from C57BL/6 hearts five days after LAD occlusion 
or sham surgeries
10
Figure 2.2: Quantitative PCR analysis for the expression of Wnt pathway intermediates. Quantitative real-time RT-PCR 
analysis for the expression of wnt pathway mediators was performed on mRNA isolated from the hearts of C57BL/6 mice 
five days after being subjected to either permanent LAD occlusion or sham surgeries. *P<0.05, **P<0.01, ***P<0.001. Sham 
N=6; MI N=6
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Immunohistological analysis for changes in β−catenin expression revealed an increase in 
β−catenin staining at the cardiomyocyte intercalated disc 24 hours after MI (Fig 2.3), 
followed by an increase in cytoplasmic and nuclear β−catenin 7 days after MI (Fig 2.4).  
 
 
24hrs post-MI SHAM 
Figure 2.3: Increased β−catenin immunoreactivity at the cardiomyocyte intercalated disc 24 hours 
after experimental MI.  C57BL/6 mice were subject to LAD occlusion or sham surgeries. Hearts were 
isolated 24 hours after surgery and stained for β−catenin 
 
The increase in wnt pathway intermediates, such as β−catenin, after MI do not 
necessarily mean that canonical wnt signaling is activated, as molecules like the retinoic 
acid receptor can prevent stabilized β−catenin from interacting with TCF/LEF factors and 
activating transcription of target genes. Therefore, to more directly assess canonical wnt 
signaling activity, we turned to the TOPGAL transgenic canonical wnt reporter mouse 
line to evaluate canonical wnt activity in the healthy adult mouse heart and after MI. 
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SHAM 7 days post- MI
Figure 2.4: Increased cytoplasmic and nuclear β−catenin 7 days after MI. C57BL/6 mice were subject 
to LAD occlusion or sham surgeries. Hearts were isolated 7 days after surgery and stained for the canonical 
wnt activator, β−catenin (red) and smooth muscle actin (green). Notice that in the sham heart, smooth 
muscle actin-positive cells are contained within blood vessels but after MI, there are migratory smooth 
muscle actin-positive cells (myofibroblasts) that have β−catenin in their nuclei.
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Canonical wnt signaling is active in the vasculature and valves of the adult mouse heart 
To appreciate changes in canonical wnt signaling after ischemic injury following arterial 
ligation, canonical wnt/β−catenin signaling in the normal adult heart was first analyzed.  
To this end, hearts of TOPGAL mice were isolated and subjected to whole mount 
staining for β-galactosidase activity and serial histological analysis (Fig. 2.5).  The results 
show that in the normal heart, canonical wnt signaling activity is present primarily in 
large blood vessels at the base of the heart and the valves (Fig. 2.5 A,B).  Histological 
sections revealed that β−catenin signaling is active in the media and intima of the aorta 
and pulmonary vessels, and in the valve mesenchyme. Furthermore, there is activity in 
coronary vessels and subepicardial microvasculature (Fig. 2.5 C). 
 
The staining patterns suggest that canonical wnt activity marks subpopulations of both 
endothelial and smooth muscle cells in the heart.  To confirm this finding, histological 
sections stained with antibodies against the endothelial-specific marker CD31 (PECAM-
1) and smooth muscle actin (SMA) were analyzed (Fig. 2.6 A,B).  The results confirmed 
expression in subsets of smooth muscle and endothelial cells.  Taken together, the results 
suggest that during cardiac homeostasis, canonical wnt activity is confined in select 
subpopulations of endothelial and smooth muscle cells as well as in valve mesenchymal 
cells. 
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AB
Great vessels Aorta Pulmonary vessel
Coronary vessel and subepicardial microvasculature
Valves Aortic valve Mitral valve
C
Fig. 2.5:  Canonical wnt signaling activity in the healthy adult mouse heart.  Whole mount and histological analyses of 
canonical wnt activity in the adult heart using the TOPGAL mouse line.  (A) X-gal-stained whole mount heart shows canonical 
wnt activity in the great vessels at the base of the heart.  Tissue sections of this area show canonical wnt activity in the media 
and intima of aortic and pulmonary vessels. (B) Whole mount X-gal staining of partially dissected heart to show cells with 
canonical wnt activity in cardiac valves (left).  Histological sections (right panels) reveal cells positive for canonical wnt 
activity in the mesenchyme of outflow tract (aortic), and atrioventricular (mitral) valves. (C) Histological section shows 
canonical wnt activity in coronary arteries and subepicardial microvasculature (right). 
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X-gal/CD31
X-gal/SMA
SMA β−gal
Merge
Aorta Pulmonary vessel
Figure 2.6: Canonical wnt signaling is active in endothelial and smooth muscle cells. (A) CD31 antibody stain 
(brown) on X-gal-stained section from great vessels of TOPGAL mouse shows canonical wnt activity in vascular 
endothelial cells (white arrow).  (B) IF images of tissue sections stained with antibodies recognizing a-SMA in 
vascular smooth muscle cells (green) and β−galactosidase (red).  Merged images show colocalization of the two 
antigens in cells of the intima and media areas of the aorta. Bottom right, SMA antibody stain (brown) on X-gal- 
stained aorta section indicates canonical wnt activity (blue) in perivascular SMA+ cells. 
A
B
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Canonical wnt signaling is activated in the infarct and peri-infarct areas during 
granulation tissue formation 
 
To test whether the pattern of canonical wnt pathway is altered in response to myocardial 
infarction, TOPGAL mice were subjected to LAD occlusion or sham surgeries, hearts 
were isolated at defined time points after arterial ligation, i.e. at 24 hours post-MI during 
the cell death and inflammation phase, 4-7 days during granulation tissue formation and 3 
weeks when scar tissue had matured, and then stained for β-galactosidase activity (Fig. 
2.7).   
3 WKS 
SCAR  
FORMATION 
4-7 DAYS 
GRANULATION 
TISSUE 
FORMATION
24 HRS  
CELL DEATH 
INFLAMMATION 
SHAM OR 
 LAD  
OCCLUSION 
 
Figure 2.7: Experimental Scheme: The post-MI timepoints at which TOPGAL mouse 
hearts were isolated and stained for β−galactosidase activity. 
 
The results show that canonical wnt signaling is not activated as part of the early 
infarction response as the β−galactosidase activity in TOPGAL mouse hearts isolated 
within the first 24 hours after coronary artery ligation is practically indistinguishable 
from sham-operated controls (Fig. 2.8).  In contrast, canonical wnt positive cells appear 
scattered throughout the myocardium 4 days after LAD ligation.  By 7 days post-MI, 
canonical wnt activity is primarily localized to large numbers of cells within the infarct 
and peri-infarct areas. This activity is transient and disappears by the time of scar 
maturation, 3 weeks post-infarction.   
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Figure 2.8: The canonical wnt signaling pathway is activated during the granulation tissue formation stage of the MI response. Experimental model of MI was induced by 
subjecting TOPGAL mice to LAD occlusion or sham surgeries. Hearts were isolated at defined stages of the MI response process and stained with X-gal to assess canonical wnt 
activity. Panel 1: Whole mount X-gal-stained sham heart shows gross canonical wnt activity is limited to the great vessels. Panel 2: Whole mount X-gal-stained heart 24hrs after LAD 
occlusion shows induction of the canonical wnt signaling pathway does not occur in the early stages of the myocardial infarction response. Panel 3: Whole mount X-gal-stained heart 
demonstrates novel activation of the canonical wnt signaling pathway throughout the myocardium 4 days after LAD occlusion. Panel 4: Whole mount X-gal-stained heart shows that 
induced canonical wnt activity becomes limited to the peri-infarct area 7 days after LAD occlusion. Panel 5: Whole mount X-gal-stained heart shows that infarction-induced 
canonical wnt activity is down-regulated by 3 weeks. Top images show anterior views, middle images show posterior views and bottom images represent higher magnifications of 
areas distal to LAD occlusion. 
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Interestingly, the severity of the injury, estimated by echocardiography-based 
measurements of fractional shortening and other cardiac functional parameters, directly 
correlates with post-MI day 7 levels of canonical wnt activity as assessed by 
β−galactosidase staining, suggesting a role for canonical wnt positive cells in the cardiac 
tissue repair process during granulation tissue formation (Fig. 2.9). 
 
 
Figure 2.9: Peri-infarct canonical wnt activity correlates to infarct severity. Myocardial infarctions of 
different severities were performed in TOPGAL mice by varying the heights of LAD ligation sutures. 7 
days after surgery, echocardiography was performed to evaluate cardiac function. Hearts were then isolated 
and X-gal stained to assess canonical wnt activity in relation to infarct severity.  
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Canonical wnt targets are induced during post-MI granulation tissue formation 
As an independent read-out for canonical wnt pathway activation, real-time quantitative 
PCR analysis was performed to follow the expression of down-stream gene targets of the 
β−catenin signaling pathway at the defined MI response stages. 
 
Consistent with the timing of β-galactosidase staining in TOPGAL mice post-MI, real-
time quantitative PCR analysis shows a strong up-regulation of bona-fide β−catenin 
signaling gene targets such as c-Fos, c-Myc, Wnt-10b, Wisp1, Tcf7 and Snail seven days 
post-MI (Fig. 2.10).  Among tested canonical wnt signaling targets, the early response 
genes, c-Fos and c-Myc show the strongest induction at 24 hours, probably through 
canonical wnt-independent pathways.   
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Figure 2.10: Canonical wnt targets are induced after MI. Real-time quatitative RT-PCR analysis 
for the expression of canonical wnt targets was performed on mRNA isolated from TOPGAL 
mouse hearts at defined stages of the myocardial infarction response process. *P<0.05, **P<0.01, 
***P<0.001. Sham N=6; 24hr N=3; 7-day N=6; 3-week N=3.  
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Canonical wnt signaling is activated in endothelial and mesenchymal cells after MI  
Granulation tissue formation is characterized by endothelial cell proliferation and 
migration to form new blood vessels and myofibroblast activation and migration to lay 
down collagen for subsequent scar formation.  To identify the cell types marked by 
canonical wnt signaling activity during this stage, histological sections of TOPGAL 
mouse hearts 7 days after LAD occlusion or sham surgery were analyzed.  The analyses 
show that surrounding the infarct area after MI, there is an increase in canonical wnt 
signaling active endothelial cells.   
 
However, the intense staining observed in the whole-mount images at day 7 post-MI (Fig. 
2.8) is mainly due to the de novo appearance of large numbers of subepicardial 
mesenchymal-like cells marked with canonical wnt signaling activity (Fig. 2.11 A and 
B). It should be noted that canonical wnt active-mesenchymal cells are not present in the 
subendocardium (Fig. 2.11 C).   
 
 
 
 
 
 
 
 
 
 22
Sham 7d post-MI
Subepicardium
Subendocardium
Figure 2.11: Canonical wnt signaling is active in peri-infarct endothelial and mesenchymal cells after MI. 
Histological analysis of canonical wnt activity was performed on TOPGAL mouse hearts 7 days after LAD 
occlusion or sham surgery. Tissue sections of X-gal-stained mouse hearts shows that in sham cardiac tissue, β−
 
galactosidase/canonical wnt signaling activity is limited to the endothelium and pericytes of coronary vessels and in 
microvascular endothelial cells (left panel).  After MI, in addition to coronary vasculature and microvasculature, 
canonical wnt signaling marks newly appearing subepicardial mesenchymal-like cells surrounding the infarct area 
and a subset of epicardial cells. In contrast, canonical wnt signaling active-cells are not present in subendocardial 
regions (bottom panel).  
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Immunohistochemical (IHC) and immunofluorescence (IF) analyses using antibodies 
recognizing the endothelial marker CD31 and the myofibroblast marker SMA confirmed 
that post-MI canonical wnt signaling is active in endothelial cells and SMA-expressing 
mesenchymal cells in the infarct and peri-infarct areas (Fig. 2.12 A,B).   
 
To get a measure of the scale of the increase in canonical wnt activity, canonical wnt-
positive endothelial and mesenchymal cells in the infarct and peri-infarct areas were 
counted and cell counts were compared to canonical wnt-active cell counts in the 
corresponding cardiac tissue sites of sham-operated mice.  The results showed that the 
fraction of endothelial cells marked with β-galactosidase activity increases from about 
30% in normal subepicardial heart tissue to 50% after MI.  In parallel, the overall fraction 
of β-galactosidase positive SMA-expressing cells rises from almost undetectable levels to 
12% of the entire subepicardial cell population.  The quantitative cell count analysis also 
shows that canonical wnt-active SMA+ mesenchymal cells represent about 40% of SMA+ 
cells in the peri-infarct subepicardial area (Fig. 2.13 A). Interestingly, the number of 
SMA+ cells in the infarcted myocardium, as measured by FACS analysis, correlates with 
the severity of injury as assessed by echocardiographic measurement of fractional 
shortening (Fig. 2.13 B).  
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Figure 2.12: Post-MI canonical wnt active cells express CD31 and Smooth muscle actin. (A) IHC using the anti-CD31 antibody on X-gal stained cardiac tissue shows 
canonical wnt activity (blue) in endothelial cells (brown) in the peri-infarct area (white arrows).  The three left panels display IF results obtained using the anti- β−galactosidase 
(green) and CD31 (red) antibodies and the corresponding merged image.  Canonical wnt activity marks endothelial cells (white arrows).  Examples of endothelial cells without 
canonical wnt activity (red arrows) and non-endothelial, canonical wnt-pathway active cells (green arrows) are indicated. (B) IHC analysis using the anti-α−SMA antibody on 
sections of X-gal stained cardiac tissue from TOPGAL mice shows canonical wnt activity (blue) in SMA+ cells (brown) in the peri-infarct area (white arrows).  The three left 
panels display IF results obtained using the anti- β−galactosidase (green) and α−SMA (red) antibodies and the corresponding merged image. Canonical wnt activity marks 
SMA+ cells (white arrows).  Green arrows point to SMA- cells with canonical wnt-pathway activity and red arrows to SMA+ cells lacking canonical wnt activity. 
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Figure 2.13: Significant increase in canonical wnt-active cells after MI. (A) Canonical wnt-activity-marked 
endothelial cells were quantified by counting the number of double X-gal-stained and CD31-positive cells per visual 
field.  Canonical wnt-active SMA+ cells were quantified by counting the number of SMA-expressing X-gal-positive 
cells as a percentage of the total cell population in a given visual field, or as a percentage of the total SMA+ cell 
population.  *P<0.05, **P<0.01, ***P<0.001, NS: not significant.  Control sham N=5; MI samples N=5. (B) Percentage 
of SMA+ cells correlates to infarct severity. Echos were performed on mice 7 days after LAD occlusion or sham 
surgeries. Hearts were then isolated and subjected to FACS analysis with anti-SMA antibody.
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Discussion 
The canonical wnt signaling pathway may be an important MI therapeutic target because 
transplanted stem/progenitor cells which yield beneficial paracrine effects after cardiac 
injury have been shown to express wnt pathway mediators (Kupatt et al., 2005b; 
Mirotsou et al., 2006; Alfaro et al., 2008). In addition, endogenous wnt pathway 
intermediates are increased after myocardial infarction (Blankensteijn et al., 2000; 
Barandon et al., 2003; Chen et al., 2004; Kobayashi et al., 2009). However, because 
controversies exist as to the effect wnt pathway manipulation has on post-infarction 
cardiac wound healing and remodeling, we sought to study post-MI canonical wnt 
signaling activity in more detail.  
 
Our results show that in the normal, uninjured mouse heart, there is active canonical wnt 
signaling in subpopulations of endothelial cells and pericytes mainly around the aorta and 
pulmonary vessels, in coronary arteries and subepicardial microvasculature.  Moreover, 
interstitial cells marked with canonical wnt activity are present within the connective 
tissue of the valve leaflets.  After MI, there is an increase in canonical wnt active-cells 
that begins at 4 days and is followed by a massive accumulation of canonical wnt-
positive cells in the infarct and peri-infarct areas 7 days post-MI.  Therefore, it appears 
that canonical wnt signaling does not play a significant role in the original stages of 
ischemic injury during cardiomyocyte death and inflammation.  Instead, its activity peaks 
in late reparative processes, during granulation tissue formation, where the number of 
canonical wnt positive cells directly correlates with the severity of the original ischemic 
injury. 
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Consistent with the whole mount and histological staining for β-galactosidase/active β-
catenin, the expression of known canonical wnt signaling targets also shows maximum 
levels during the same time – with the exception of c-Fos and c-Myc which are induced 
shortly after infarction. These results are in agreement with a recent study, which showed 
that the activity of the Axin2 promoter, a canonical wnt signaling target, also reaches its 
height 1-2 weeks after experimental MI (Oerlemans et al., 2010). 
 
Taken together, the results show that the canonical wnt signaling pathway is induced 
during post-MI granulation tissue formation, a period characterized by proliferation and 
migration of endothelial cells and myofibroblasts. Consistent with this, the induced 
canonical wnt signaling activity is observed in these cell types. The question of what 
process or processes canonical wnt pathway activation mediates in endothelial cells and 
myofibroblasts is addressed in subsequent chapters. 
 
Methods 
Mice 
The TOPGAL mice express β−galactosidase under the control of β−catenin-responsive 
consensus LEF/TCF-binding motifs upstream of a minimal c-fos promoter promoter 
(DasGupta and Fuchs 1999).  All procedures were carried out with the approval of the 
Institutional Animal Care and Use Committee of Vanderbilt University Medical Center.  
The TOPGAL mouse line was purchased from Jackson Laboratories.   
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Experimental myocardial infarction 
Mice underwent open chest surgery under anesthesia.  During surgery, a 10−0 nylon 
suture was placed through the myocardium into the anterolateral Left Ventricular wall 
around the left anterior descending artery and the vessel was permanently ligated.  After 
surgery, the chest was closed and the animals were allowed to recover.  At defined time 
points after surgery, i.e., 1 day, 4 days, 1 week and 3 weeks, mice were euthanized and 
whole hearts were isolated for whole-mount X-Gal staining and histological analysis, or 
used to obtain RNA for gene expression studies.  Sham-operated animals underwent 
similar procedures without coronary artery ligation.  Surgeries were performed in the 
Vanderbilt mouse Cardiovascular Pathophysiology & Complications Core.  
 
Echocardiography 
Two-dimensional M Mode echocardiography was performed on conscious hand held-
restrained mice using a 15-6L probe. Analysis was performed on HP Sonos 5500. 
 
β-galactosidase activity whole tissue staining assay 
Whole hearts were isolated into cold 1X phosphate-buffered saline (PBS) and then fixed 
for 30 minutes at 4oC in 1X PBS solution containing 1% formaldehyde, 0.2% 
glutaraldehyde and 0.02% NP40.  After fixation, hearts were washed twice with 1X PBS 
for 20 minutes each, and then placed overnight at 30oC in X-gal staining solution 
(1mg/mL X-gal, 5mM potassium ferro- and ferricyanate and 2mM magnesium chloride 
in 1X PBS).  Whole mount hearts were photographed and then stored in 1X PBS at 4oC 
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until embedded in paraffin and cut in 5 μm sections.  Sections were deparaffinized, 
counter-stained with eosin, dehydrated and mounted.  
 
Immunofluorescence (IF) and immunohistochemistry (IHC) 
For IF experiments, freshly isolated hearts were embedded in Optimal Cutting 
Temperature compound (OCT) and cut in 5 μm sections.  Before antibody staining, slides 
were thawed at room temperature, immersed in 4% para-formaldehyde and fixed for 5 
minutes on ice.  Slides were washed three times in 1X PBS for 5 minutes each wash.  
Sections were blocked in a 1X PBS solution of 1% bovine serum albumin and 0.05% 
saponin for 1 hour at room temperature.  Sections were then incubated with primary 
antibodies overnight at 4oC.  Afterwards, slides were washed three times in 1X PBS for 5 
minutes each, incubated with secondary antibodies for 1 hour at room temperature, 
washed in 1X PBS three times for 5 minutes each, and mounted with Vectashield 
fluorescent mounting medium (Vector Laboratories).  
 
For IHC stains, 5 μm sections of LacZ-stained paraffin-embedded hearts were 
deparaffinized through histoclear and graded alcohols as per standard protocol.  
Endogenous peroxidase activity was quenched by immersing slides in 0.3% peroxidase 
dissolved in blocking solution for 5 minutes at room temperature.  Sections were then 
blocked and stained with primary antibodies as described above for IF.  Afterwards, 
sections were washed three times for 5 minutes each in 1X PBS and then incubated with 
ImmPress Universal reagent (Vector laboratories) when mouse or rabbit primary 
antibodies were used, or with Anti-Rat Ig Horse Rabbit Peroxidase detection kit (BD 
Pharmingen) when rat primary antibodies were used.  Kits were used according to 
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manufacturers’ instructions.  Slides were counter-stained, dehydrated and mounted with 
Permount histological mounting medium (Fisher).  Histological services were perfomrd 
by the Vanderbilt Histology Core. 
 
Antibodies used for histological analysis and their various dilutions in blocking solution 
were: Rabbit IgG fraction against β−galactosidase (Cappel Pharmaceuticals; 1:2,000 
dilution), monoclonal Mouse anti-β−catenin (Sigma; 1:800 dilution) monoclonal Mouse 
anti-smooth muscle alpha actin (Sigma; 1:800 dilution) and Rat anti-mouse 
CD31/PECAM1 (BD Pharmingen; 1:100 dilution).  
 
Secondary antibodies used for IF were: Goat anti-Mouse Cy3-conjugated, Donkey anti-
Rabbit Cy3, Goat anti-Rat Cy3, Goat anti-Mouse Alexa488 and Goat anti-Rabbit 
Alexa488.  Cy3-conjugated antibodies were obtained from Jackson Immunoresearch and 
Alexa488-conjugated antibodies from Invitrogen.  All secondary antibodies were used in 
a 1:200 dilution.  To visualize and quantify cells in IF experiments, cardiac tissue 
sections were stained with the fluorescent dye DAPI (4',6-diamidino-2-phenylindole) 
(1:5,000 dilution; Invitrogen) to mark cellular nuclei. 
 
FACS analysis 
Suspensions of cardiac cells depleted of myocytes were prepared as follows.  Murine 
hearts were washed to remove blood and aseptically isolated after incision at the base of 
the aorta.  The atria were entirely removed.  The heart’s ventricles were minced and 
digested with 10 mg/ml collagenase II (Worthington), 2.4 U/ml dispase II (Roche 
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Diagnostics), DNase IV (Sigma) in 2.5 mM CaCI2 at 37oC for 20-25 minutes and then 
passed through a cell strainer. The myocyte-depleted cell suspension was centrifuged at 
1,500 x g for 5 minutes and resuspended in 1X PBS containing 0.5% bovine serum 
albumin (BSA) and 2 mM EDTA. 
 
To prevent non-specific binding, cells were incubated with FcR Blocking Reagent 
(Miltenyi Biotec Inc).  For intracellular staining to detect α-smooth muscle actin (α-
SMA), cells were fixed and permeabilized using 4% paraformaldehyde and 0.1% saponin 
in 1X PBS.  Aliquots of cells (105 cells in 100 µL buffer) were incubated with fluorescein 
isothiocyanate (FITC)-conjugated anti-α-SMA (Sigma) for 30 minutes at 4oC.  Next, 
cells were washed once with 0.1% saponin and resuspended in 1X PBS containing 0.5% 
BSA and 2 mM EDTA.  Data acquisition was performed on a FACScalibur flow 
cytometer (BD Immunocytometry Systems) in the Vanderbilt Flow Cytometry Core and 
the data were analyzed with the WinList 5.0 software.  Antigen negative background 
binding was defined by the fluorescent intensity of isotype controls. 
 
Quantitative RT-PCR analysis 
Total RNA was isolated from mouse hearts using the Trizol reagents (Invitrogen) 
following the manufacturers’ instructions. To reverse-transcribe RNA into cDNA, 3 μg 
of RNA was mixed with 100 ng oligo(dT)15 and incubated for 5 minutes at 65°C.  1 mM 
dNTPs, 60 mM KCl, 15 mM Tris-Cl pH 8.4, 3 mM MgCl2, 0.3% Tween 20, 10 mM β-
mercaptoethanol, 10 U RNasin (Promega), and 100 U Mo-MLVRT (Invitrogen) were 
added, and the mix was incubated for 55 minutes at 37°C.  Enzyme was inactivated by 
 32
incubating at 95°C for 5 minutes.  In order to perform PCR, 20 ng cDNA was incubated 
with Taq DNA polymerase (Promega) and respective primers at 0.25 μM concentration 
for 35 cycles (1 minute at 95°C, 1 minute 60-65°C, and 1 minute 72°C).  β-actin or 
Gapdh were used as internal controls.  Quantitative PCR was performed using the iQ 
SYBR Green Supermix kit (BioRad) on an iCycler (BioRad).  Relative gene expression 
levels were quantified using the 2(-DDCt) formula (Livak and Schmittgen, 2001). Primer 
sequences have been included in Table 1. 
 
Statistical analysis 
The GraphPad Prism software was used to handle data.  Results are reported as mean + 
S.E.M.  Student’s t-test was used for comparing two groups. *P<0.05, **P<0.01, 
***P<0.001. 
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CHAPTER III 
 
CANONICAL WNT PATHWAY ACTIVATION DURING POST-MI 
GRANULATION TISSUE FORMATION COINCIDES WITH ENDOTHELIAL-
TO-MESENCHYMAL TRANSITION 
 
 
Introduction 
The concurrent activation of canonical wnt activity in endothelial cells and SMA+ 
mesenchymal cells raised the possibility that the latter are derived from activated 
endothelium. Consistent with this notion, endothelial-to-mesenchymal transition 
(EndMT) has been linked to angiogenesis, where tip cells acquire a mesenchymal 
phenotype during vessel branching (Gerhardt et al., 2003). EndMT has also been linked 
to myofibroblast activation and subsequent cardiac fibrosis after aortic banding (Zeisberg 
et al., 2007). We reasoned that since the granulation tissue formation phase of the MI 
response is characterized by neovascularization and myofibroblast activation, EndMT 
may play a role in this phase of the MI response. Furthermore, because we observed that 
the canonical wnt signaling pathway is activated in endothelial and mesenchymal cells 
during post-MI granulation tissue formation, we reasoned that canonical wnt signaling 
may mediate EndMT after MI. 
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Results 
Endothelial-to-mesenchymal transition at homeostasis in the vasculature and valves of 
the adult mouse heart 
 
In order to evaluate de novo EndMT after ischemic injury following arterial ligation, 
EndMT in the normal, uninjured adult heart was first analyzed.  To this end, the 
endothelial-SCL-Cre-ERT mouse line, in which the 5’ endothelial-specific enhancer of 
the stem cell leukemia (SCL) locus drives tamoxifen-inducible Cre-ERT (Göthert et al., 
2004) was crossed to the R26RstoplacZ mouse line (Soriano, 1999). The SCL gene is 
expressed in both haematopoietic and endothelial cells (Schlaeger et al., 2005; Gottgens 
et al., 2002; Sanchez et al., 1999). However, the 5’ enhancer has been shown to be 
exclusively active in endothelial cells thus allowing specific and permanent genetic 
labeling of endothelial cells and their progeny (Sinclair et al., 1999; Gothert et al., 2004). 
 
Adult progeny of the double transgenic line SCL-Cre-ERT/R26RstoplacZ, named End-
SCL-LacZ mice, were injected with tamoxifen to induce Cre recombinase and labeling of 
endothelial cells. The results show that in the normal healthy adult mouse heart, most of 
the LacZ labeling is observed in vascular endothelium. Interestingly, there are some 
LacZ-expressing cells in the media of the great vessels and in the valve mesenchyme, 
suggesting that endothelial-to-mesenchymal transition occurs basally in the great vessels 
and valves (Fig 3.1 A). It should be noted that within the myocardium, LacZ labeling is 
limited to coronary and microvascular endothelial cells; LacZ-expressing peri-vascular or 
other mesenchymal-like cell are not detected in the healthy myocardium (Fig 3.1 B).  
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AFigure 3.1: EndMT at homeostasis in great vessels and valves at the base of the heart. Hearts were isolated from tamoxifen- 
treated end-SCL-LacZ mice. A. X-gal stain lineage tracing reveals the presence of endothelial-derived mesenchymal cells in 
great vessels and valves at the base of the heart. B. Section through left ventricle shows that there is no mesenchymal labeling 
within the myocardium; only endothelial cells are labeled
B
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Cells co-expressing CD31 and Smooth muscle actin are increased during post-MI 
granulation tissue formation 
 
One hallmark feature of EndMT is the appearance of cells dually positive for endothelial 
and mesenchymal gene markers such as CD31 and SMA (Paruchuri et al., 2006; Sales et 
al., 2006; Goumans et al., 2008). To examine whether CD31+/SMA+ cells appear after 
experimental MI, cardiac tissue sections were analyzed by immunostaining.  The results 
show a significant number of dually positive CD31+/SMA+ cells suggesting that EndMT 
takes place post-MI (Fig. 3.2 A).   
 
To verify and quantify these results, cardiac tissues from mice that had undergone LAD 
occlusion or sham surgery were dissociated to single cell preparations 7 days after 
surgery, stained with antibodies against CD31 and SMA and analyzed by FACS.  As 
shown in Fig. 3.2 B, there is a significant increase in CD31lowSMAlow double positive 
cells 7 days post-MI.  Specifically, CD31+SMA+ cells rise from less than 1% in normal 
cardiac tissue to almost 25% of the total cell number (Fig. 3.2 C). 
 
 
 
 
 
 
 
 
 
 37
A20μm 20μm 20μm
20μm 20μm 20μm
CD31 SMA Merge
20μm 20μm 20μm
18μm
10 1 10 2 10 3 10 4
SMA FITC-A
1
0
1
1
0
2
1
0
3
1
0
4
C
D
3
1
 
P
E
-
A
R2: 37.2%
R3: 0.1%
R4: 0.7%
Sham
10 1 10 2 10 3 10 4
SMA FITC-A
1
0
1
1
0
2
1
0
3
1
0
4
C
D
3
1
 
P
E
-
A
R2: 15.2%
R3: 4.8%
R4: 24.5%
7d post-MI
SMA FITC
C
D
3
1
 
P
E
B C
Figure 3.2: Increase in cells co-expressing CD31 and SMA during post-MI granulation tissue formation. (A) Immunohistological analysis with CD31 (red) and smooth muscle actin 
(green) antibodies, performed on sections from mouse hearts isolated 7 days after MI, shows the presence of cells co-expressing CD31 and smooth muscle actin (merge). (B) FACS analysis 
with CD31 and smooth actin antibodies was performed on peri-infarct tissue isolated 7 days after MI or sham surgeries. There is a marked increase in the CD31lowSMAlow population of 
cells on post-MI day 7. (C). Graph of average from FACS analysis. Sham N = 3; MI N = 3. *P<0.05, **P<0.01, ***P<0.001.  
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EndMT-associated genes are induced during granulation tissue formation after MI 
Other genes that have been linked to mesenchymal transition include Snail (Medici et al., 
2006; Kokudo et al., 2008), Fsp1 (Zeisberg and Neilson 2009), Vimentin (Milsom et al., 
2008), MMP2 (Song et al., 2000; Duong and Erickson 2004), Tgfβ1 (Wang et al., 2005; 
Deissler et al., 2006; Tavares et al., 2006; Zeisberg et al., 2007; Goumans et al., 2008) 
and Col1A1 (Zeisberg et al., 2007; Hashimoto et al., 2010).  Quantitative real-time RT-
PCR analysis for the expression of EndMT-related genes at different time points after MI 
revealed that the peak in the expression of genes such as Snail, Fsp1, Tgfβ1, Vimentin 
and Col1a1 corresponds to the appearance of CD31+/SMA+ cells on day 7 post-MI (Fig. 
3.3).   
 
Taken together, the results suggest that EndMT takes place after ischemic injury, and 
reaches its highest point during granulation tissue formation.   
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Figure 3.3: EndMT-associated genes are induced during granulation tissue formation. Real-time quatitative RT- 
PCR analysis for the expression of EndMT-associated genes was performed on mRNA isolated from TOPGAL 
mouse hearts at defined stages of the myocardial infarction response process. 
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Post-MI myofibroblasts are endothelial-derived 
To confirm the endothelial origin of peri-infarct mesenchymal cells, End-SCL-LacZ mice 
were injected with tamoxifen to induce Cre recombinase and labeling of endothelial cells.  
One week after the last tamoxifen dose, the mice underwent LAD or sham surgery, and 
histological analyses were performed seven days after surgery (Fig 3.4 A). The analyses 
showed that in sham-operated mice, ventricular β-galactosidase expression is limited to 
endothelial cells.  In contrast, the cardiac tissues of mice subjected to LAD occlusion 
have both increased LacZ-positive endothelial cells and a novel population of β-
galactosidase-expressing mesenchymal cells (Fig. 3.4 B).  Anti-SMA staining confirmed 
the presence of double positive β-galactosidase/SMA cells in peri-vascular and 
subepicardial peri-infarct regions (Fig. 3.4 C).   
 
Quantification of histological sections showed that β-galactosidase+/SMA+ cells represent 
35-40% of the subepicardial SMA+ cell population (Fig. 3.4 D).  Because tamoxifen 
induction labels only a fraction of resident endothelial cells, it is likely that this number is 
an underestimation of the endothelium-derived SMA+ cells.  
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Figure 3.4: EndMT is induced during granulation tissue formation. Tamoxifen-treated End-SCL-LacZ mice were 
subject to LAD occlusion or sham surgeries. A. Experimental scheme. Lineage tracing reveals increased endothelial 
labeling after MI and the presence of endothelial-derived mesenchymal cells in the day 7 MI, but not in the sham, 
myocardium (B and C). C and D. Immunohistochemical stain with smooth muscle actin antibody was performed on 
heart sections from End-SCL-LacZ mice isolated 7 days after coronary ligation. Endothelial-derived myofibroblasts 
are observed in the peri-infarct subepicardial region.  
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Canonical wnt signaling is active in endothelial-derived mesenchymal cells 
By lineage tracing with the End-SCL-LacZ mouse line, we observe basal EndMT in the 
great vessels and valves of the healthy adult mouse heart. These areas, the great vessels 
and valves, are the areas in which we observe the highest levels of canonical wnt 
signaling activity in the healthy adult mouse heart. This pattern of canonical wnt 
signaling activation in areas undergoing EndMT suggests a link between canonical wnt 
signaling and EndMT in the adult heart. This link is further supported by the finding that 
after MI, peak canonical wnt pathway signaling coincides with the time of highest 
EndMT. Therefore, we investigated whether canonical wnt signaling is active in EndMT-
derived mesenchymal cells after MI. 
 
 To this end, cardiac tissue sections of TOPGAL mice 7 days post-MI were stained with 
antibodies to β−galactosidase and the mesenchymal transition-inducing gene, Snail.  The 
results show that Snail is expressed in cells marked by canonical wnt signaling activity 
(Fig. 3.5).  Furthermore, analysis of cardiac tissue sections of tamoxifen-treated End-
SCL-LacZ mice obtained 7 days after LAD or sham surgery shows nuclear β−catenin in 
β-galactosidase stained mesenchymal cells of endothelial origin (Fig. 3.6). 
 
Taken together, the results show that canonical wnt signaling is active in cells undergoing 
EndMT. 
 
 
 
 43
18μm Merge18μm Snail18μm β−gal
Figure 3.5: Cells in which canonical wnt signaling is activated express the EndMT-associated gene, Snail. 
IF analysis on sections from TOPGAL mouse hearts 7 days after experimental MI using the anti- β−
 
galactosidase (green) and Snail (red) antibodies.  
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Figure 3.6: Canonical wnt signaling is active in EndMT-derived mesenchymal cells. IHC analysis using the anti- 
β−catenin antibody on sections of X-gal-stained cardiac tissue of tamoxifen-treated End-SCL-Cre/Rosa-LacZ mice 7 
days post-MI.  Left panel: sham control shows β−catenin accumulation in the intercalated disks of cardiomyocytes 
(white arrowheads) and a subset of endothelial cells (white arrows).  Middle and right panels: 7 days post-MI, 
nuclear β−catenin is also present in mesenchymal cells (black arrows).  Right panel depicts a greater magnification 
of area boxed in the middle image. 
50μm
Sham 7d post-MI
X-gal/β−catenin
50μm50μm
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Discussion 
EndMT has been extensively studied during heart development. EndMT occurs during 
aortic and pulmonary vessel development (Arciniegas et al., 2005), as well as during 
valve development (Yamagushi et al 1999, Sugi et al 2004, Lincoln et al 2004, reviewed 
by Armstrong and Bischoff 2004). A role for canonical wnt signaling in cardiac cushion 
EndMT has been demonstrated by studies showing canonical wnt activation in 
developing mouse cardiac cushions (Gitler et al 2003), studies showing disruption of 
valve formation upon interruption of canonical wnt signaling in zebrafish (Hurlstone et al 
2003), and studies showing the requirement of endothelial β−catenin for proper mouse 
cushion development (Liebner et al 2004). Our results indicate that canonical wnt 
signaling and EndMT persist in the adult mouse valves, and also persist in the adult great 
vessels, where the endothelium serves as a source for peri-vascular smooth muscle cells. 
 
EndMT is emerging as a source for pro-fibrotic fibroblasts and myofibroblasts in a wide 
range of diseases. A number of mouse lineage tracing studies reveal that EndMT 
contributes to fibrosis in models of chronic renal (Zeisberg et al 2008), pulmonary 
(Hashimoto et al 2009), and heart (Zeisberg et al 2007; Widyantoro et al 2010) disease. 
Our lineage tracing study with the End-SCL-LacZ mouse line implicates the mature 
endothelium as a major source of myofibroblasts after MI.  
 
The possibility that the End-SCL locus becomes activated so that Cre expression and 
lacZ labeling occurs in post-infarction myofibroblasts independently of endothelial 
origin, is very small because tamoxifen injections end fourteen days before hearts are 
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isolated and sections analyzed (fig 3.4 A); such an occurrence will suggest that Cre 
activation occurs independently of tamoxifen, which is unlikely as we and others 
(Sinclair et al., 1999; Gothert et al., 2004) have not observed this.  
 
The argument can be raised that activation of the End-SCL locus, Cre expression and 
LacZ labeling occurs in circulating endothelial progenitors rather than mature endothelial 
cells, implying that our observed post-infarction LacZ-expressing myofibroblasts are 
bone marrow- rather than mature endothelial-derived. This argument is refuted by FACS 
analyses data on cells isolated from the bone marrow of End-SCL-EYFP mice which 
showed that the End-SCL locus is not active in the adult mouse bone marrow; EYFP-
expressing cells were not detected in the bone marrow (Gothert et al., 2004).  
 
Our study is therefore the first report to implicate EndMT as a major player in cardiac 
tissue repair after acute ischemic injury since our results show to that EndMT occurs after 
acute myocardial infarction, during granulation tissue formation.  
 
In addition to the generation of fibrous scar-forming myofibroblasts, the granulation 
tissue formation stage of the MI response is characterized by new blood vessel formation, 
or neovascularization. Our data showing the occurrence of EndMT during granulation 
tissue formation suggest EndMT also contributes to neovascularization. A role for 
EndMT in new blood vessel formation is supported by Gerhardt and colleagues’ study 
which showed that during vessel branching, endothelial cells acquire a mesenchymal 
phenotype (Gerhardt et al 2003). Tumor studies showing attenuation of angiogenesis 
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upon inhibition of EndMT-associated genes further support the link between EndMT and 
angiogenesis (Singh et al 2008; Lahat et al 2010). 
 
All together, the data presented thus far show that (i). Canonical wnt signaling is 
activated during post-MI granulation tissue formation (ii). Canonical wnt activation 
during granulation tissue formation coincides with EndMT and (iii). Canonical wnt 
signaling is active in EndMT-derived cells. These results suggest, but do not directly 
show, that canonical wnt signaling mediates post-MI EndMT. The next chapter presents 
experiments that test whether activation of canonical wnt signaling in isolated endothelial 
cells is sufficient to elicit mesenchymal transition.  
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Methods 
Mice 
The SCL-Cre-ERT mouse carries a fragment of the 5’ endothelial-specific enhancer of the 
stem cell leukemia (SCL) gene locus driving the tamoxifen-inducible Cre-ERT gene 
(Göthert et al., 2004). The endothelial-SCL-Cre-ERT mice were crossed to R26RstoplacZ 
mice (Soriano, 1999) giving rise to End-SCL-LacZ mice.  Cre recombinase was induced 
by treating adult end-SCL-LacZ mice with 2mg tamoxifen (Sigma) every other day for 
ten days. Surgical procedures on End-SCL-LacZ mice were carried out one week after 
the last dose of tamoxifen treatment.  All procedures were carried out with the approval 
of the Institutional Animal Care and Use Committee of Vanderbilt University Medical 
Center.  The R26RstoplacZ mouse line was purchased from Jackson Laboratories.  The 
endothelial-SCL-Cre-ERT mouse line was a kind gift of Drs. Begley and Göthert.  
 
Experimental myocardial infarction 
Myocardial infarction was induced in mice following the protocol outlined in the 
previous chapter. 
 
β−galactosidase activity staining 
Whole hearts from End-SCL-LacZ mice were isolated at stated time points and stained 
with X-gal to assess β−galactosidase according to the previously outlined protocol. 
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Immunofluorescence (IF) and immunohistochemistry (IHC) 
IF and IHC analysis were performed as previously outlined. Mouse anti-β−catenin 
antibody (Sigma) was used in a 1:800 dilution. Mouse anti-Snail antibody (Chemicon) 
was used in a 1:600 dilution. 
 
FACS analysis 
Experiments were performed as previously described. Single-cell suspensions (106 
cells/ml) were labeled using phycoerythrin-conjugated anti-mouse CD31 (clone 390, 
eBioscience, Inc) and peridinin-chlorophyll-protein-conjugated anti-CD45 (clone 30-F11, 
eBioscience, Inc).  For intracellular staining to detect α-smooth muscle actin (α-SMA), 
cells were fixed and aliquots of cells (105 cells in 100 µL buffer) were incubated with 
fluorescein isothiocyanate (FITC)-conjugated anti-α-SMA (Sigma). 
 
Quantitative RT-PCR analysis 
Total RNA was isolated from mouse hearts using the Trizol reagents (Invitrogen) 
following the manufacturers’ instructions. Reverse transcription of RNA into cDNA and 
quantitative PCR analysis were performed as previously described. Forward and reverse 
primer sequences are listed in Table 1. 
 
Statistical analysis 
The GraphPad Prism software was used to handle data.  Results are reported as mean + 
S.E.M.  Student’s t-test was used for comparing two groups. *P<0.05, **P<0.01, 
***P<0.001. 
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CHAPTER IV 
 
CANONICAL WNT SIGNLAING TRIGGERS ENDOTHELIAL-TO-
MESENCHYMAL TRANSITION in vitro 
 
 
Introduction 
Canonical wnt signaling has been shown to be important for EndMT during embryonic 
vessel and valve development (Monkley et al., 1996; Hurlstone et al., 2003). Specifically, 
endothelial β−catenin is required for proper cardiac cushion development via EndMT 
(Liebner et al., 2004). Our observations that in the healthy adult mouse heart, EndMT 
occurs at homeostasis in regions of high basal canonical wnt activity i.e. the great vessels 
and valves, that post-MI canonical wnt activation coincides with EndMT and that the 
canonical wnt signaling pathway is active in cells that express snail, a protein that has 
been linked to mesenchymal transitions, suggest that canonical wnt signaling may 
mediate adult endothelial EndMT. 
 
To explore this possibility, we turned to the bovine aortic endothelial cell (BAEC) culture 
system, a pure population of mature endothelial cells routinely used in experiments to 
study endothelial cell behavior.  
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Results 
Canonical wnt signaling triggers mesenchymal transition in cultured mature bovine 
endothelial cells 
 
To determine if activation of canonical wnt signaling is sufficient to induce mesenchymal 
transition in a pure population of mature endothelial cells, we turned to the bovine aortic 
endothelial cell (BAEC) culture system. BAECs were treated with BIO or DMSO. We 
observed that the BIO-treated BAECs undergo dramatic morphological changes within 
24 hours acquiring a distinct mesenchymal appearance, whereas vehicle (i.e., DMSO)-
treated cells retain the characteristic cobblestone morphology of aortic endothelial cells 
(Fig. 4.1 A).  To confirm canonical wnt activation in BIO-treated cells, immunocytology 
with β−catenin antibody was performed. We observed β−catenin localization to junctions 
of DMSO-treated cells and the cytoplasm and nuclei of BIO-treated cells (Fig. 4.1 B), 
suggestive of canonical wnt activation upon BIO-treatment. 
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Untreated BIO-treated
A
B
Figure 4.1: The canonical wnt signaling pathway activator, BIO, induces mesenchymal phenotype in 
BAECs. Mature bovine aortic endothelial cells (BAECs) were cultured with BIO or with DMSO as a 
control. BIO-treatment induced a mesenchymal phenotype within 24hrs of treatment. (A) Bright-field and 
fluorescent images. (B) IF stain with β−catenin (red) and dapi (blue). 
Untreated BIO-treated
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To analyze the molecular phenotype of BIO-treated BAECs, mRNA from BIO- and 
vehicle-exposed controls were isolated 24 hours and 3 days after treatment. The response 
of a number of canonical wnt signaling targets was then analyzed by real-time 
quantitative RT-PCR using gene-specific primers.   
 
Our results show that exposure to BIO results in a 50-150-fold induction of canonical wnt 
target genes such as Tcf7 and Axin2 within 24 hours and that high levels are sustained for 
the 3-day culture period (Fig. 4.2).  BIO treatment also results in a significant decrease in 
the endothelial-cell-specific gene CD31 at both the 24 hours and 3 days time points.  
Interestingly, though the Snail-related gene Slug is moderately up-regulated within 24 
hours of exposure to BIO, other EndMT-associated genes, such as SMA and Col1A1, are 
not induced until day 3 of BIO treatment, suggesting a gradual transition to the 
mesenchymal phenotype (Fig. 4.2).   
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Figure 4.2: Canonical wnt activation down-regulates endothelial and induces mesenchymal gene expression in 
BAECs. Real-time quantitative RT-PCR analysis.  BIO-induces the expression of canonical Wnt signaling gene targets 
(Axin2, TCF7) and EndMT-associated genes (Slug, SMA, Col1A1), whereas it leads to the downregulation of the 
endothelial-specific gene CD31.  Induction of canonical wnt-pathway target genes (Axin2, TCF7) and down-regulation 
of the endothelial gene (CD31) occurs within 24 hours of BIO treatment, whereas induction of SMA and Col1A1 is not 
observed until after 3 days of exposure to BIO. 
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Inhibition of canonical wnt signaling attenuates BIO-induced EndMT 
In order to confirm that BIO-stimulated molecular alterations were specific to activation 
of the canonical wnt signaling pathway, cells were treated with the canonical wnt 
pathway inhibitor, pyrvinium (kindly provided by Drs. Curtis Thorne and Ethan Lee). As 
shown in Fig. 4.3, pyrvinium attenuates BIO effects on BAECs.  Specifically, the 
molecular analyses indicate that blocking canonical wnt signaling attenuates the 
induction of Axin2 and Sma and partially restores CD31 expression. 
 
Altogether, the in vitro experiments described above indicate that activation of the 
canonical wnt signaling pathway in mature endothelial cells induces morphological and 
molecular changes that are consistent with an initial suppression of endothelial, followed 
by an acquisition of mesenchymal characteristics.  
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Figure 4.3: Inhibition of canonical wnt signaling attenuates BIO-induced EndMT. BAECs were cultured for 3 
days with BIO in the presence of the canonical wnt inhibitor, pyrvinium. 
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Discussion 
The link between canonical wnt signaling and EndMT during heart development has been 
extensively studied, and validated in zebrafish (Hurlstone et al., 2003), chick (Arciniegas 
et al., 2005) and mouse (Liebner et al., 2004) models. Our in vivo studies showing that at 
baseline in the healthy adult mouse heart, EndMT is ongoing in areas engaged in 
canonical wnt signaling, that after MI, peak canonical wnt signaling activation coincides 
with de novo EndMT and that canonical wnt signaling is active in EndMT-derived cells, 
suggest that canonical wnt signaling mediates EndMT not only during development, but 
also in the adult heart at homeostasis and after injury.  
 
 
In this chapter, for the first time to our knowledge, we addressed the role of canonical 
wnt signaling in controlling EndMT in the mature endothelium. We used a pure culture 
of adult endothelial cells to show that activation of canonical wnt signaling is sufficient to 
induce the adult endothelium to undergo a mesenchymal transition.  
 
All together, our in vivo observations coupled with our experiments in vitro provide 
evidence that EndMT occurs in the adult cardiac endothelium at baseline, is greatly up-
regulated after injury, and is mediated by canonical wnt signaling.  
 
These observations that canonical wnt signaling induces the mature endothelium to 
undergo mesenchymal transition not only demonstrate the importance of the canonical 
wnt signaling pathway but also highlight the endothelial cell as a dynamic cell type that 
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not only reproduces itself in response to injury, but also transforms into another cell type 
to contribute even more to the wound healing process. These data thereby suggest that the 
endothelial cell can be characterized as a cardiac stem cell. This idea is probed in more 
detail in the next chapter.  
 
Methods 
Cell culture 
Bovine aortic endothelial cell culture 
Bovine Aortic Endothelial Cells (BAECs) were used between sixth and eighth passages.  
Cells were cultured in standard high glucose DMEM medium containing 10% FBS, 1% 
Pen-Strep and 1% L-glutamine.  Cells were treated with GSK-3 inhibitor IX, BIO 
(CalBiochem; 5 μM), Pyrvinium (kindly provided by Drs. Curtis Thorne and Ethan Lee; 
10nM) or the equivalent volume of vehicle solution (DMSO, Sigma). 
 
Immunocytology 
Bovine aortic endothelial cells were platted in glass chambers pre-coated with 1% 
gelatin. Upon reaching confluence, cells were treated with 5 μM BIO or DMSO and 
cultured for 24 hours. Cells were fixed for 5 minutes with 2% para-formaldehyde on ice, 
and subjected to the procedures described for immunofluorescence on tissue sections. 
 
Quantitative RT-PCR analysis 
Total RNA was isolated BAECs using the RNase easy minikit (Qiagen) following the 
manufacturers’ instructions.  
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Reverse transcription of RNA into cDNA and quantitative PCR analysis were performed 
as previously described. Forward and reverse primer sequences are listed in Table 1. 
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CHAPTER V 
 
ENDOTHELIAL CELLS DISPLAY STEM CELL CHARACTERISTICS 
 
Introduction 
It has been since established that adult endothelial cells proliferate in response to 
myocardial ischemia (reviewed by Hudlicka et al., 1992). Our lineage tracing 
experiments using the End-SCL-LacZ mice in which tamoxifen injection and endothelial 
labeling is induced in adult mice show that mature adult endothelial cells are able to 
transform into mesenchymal cells after myocardial infarction in vivo. Furthermore, our 
experiments in isolated adult bovine aortic endothelial cells show that canonical wnt 
signaling is sufficient to induce mesenchymal transition in mature endothelial cells.  Our 
data therefore add mesenchymal transformation to the repertoire of endothelial cells in 
their response to acute myocardial ischemic injury. 
 
Proliferating in response to injury, otherwise known as cell self-renewal, and 
transformation into another cell type are characteristics of stem cells. Because the 
endothelium displays both characteristics, we probed whether endothelial cells display 
other stem cell characteristics.  
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Results 
Endothelial cells proliferate at homeostasis in the healthy adult mouse heart and after 
myocardial infarction 
 
In addition to proliferation in response to injury, stem cells, by definition, proliferate 
during homeostasis for self-maintenance. To examine whether endothelial cells 
proliferate during homeostasis and after myocardial injury, immunohistological analysis 
with the endothelial-specific marker, CD31, and the pan-proliferation marker, Ki67, was 
performed on sections from mouse hearts subject to LAD occlusion or sham surgeries.  
 
The results show that endothelial cells are the dominant proliferating cardiac cell type at 
homeostasis (Fig. 5.1 A). Endothelial cells also proliferate after ischemic heart injury 
(Fig. 5.1 B). Interestingly, though little to no proliferation of other cardiac cell types is 
detected in the sham (Fig. 5.1 A; α−actinin and SMA stains), after MI, proliferation of 
SMA+ cells and few cardiomyocytes can be detected (Fig. 5.1 B).  
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CD31/Ki67 SMA/Ki67α−actinin/Ki67
UninjuredA
CD31/Ki67 SMA/Ki67α−actinin/Ki67
7d post-MIB
Figure 5.1: Endothelial cells proliferate at homeostasis and after MI. Immunofluorescence stain was performed with 
endothelial marker, CD31/PECAM (green; left panel), the cardiomyocyte marker, α−actinin (green; middle panel), the 
myofibroblast marker, SMA (green; right panel) and proliferation marker, Ki67 (red; all panels). A. Endothelial cells account 
for the majority of the proliferating cells at homeostasis. B. After MI, in addition to endothelial cells, high level of 
proliferation is observed in SMA+ myofibroblasts (right panel). Proliferation in a few α−actinin+ cardiomyocytes is also 
observed (middle panel)
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Endothelial cells express cardiac stem cell markers 
Lineage tracing experiments in mice and differentiating cultured embryonic stem cells 
have identified a number of genes to be associated with cardiac stem/progenitor cells. 
These genes include Nkx2.5 (Stanley et al., 2002), Isl-1 (Moretti et al., 2006) and Stem 
cell antigen (Sca)-1 (Wang et al., 2006). To examine whether endothelial cells express 
these genes, cardiac tissue sections were subject to immunohistological analysis with 
antibodies against endothelial cells (CD31) and cardiac stem/progenitor markers, Nkx2.5 
and Isl-1. The results show that endothelial cells express Nkx2.5 and Isl-1 as cells dually 
positive for CD31 and Isl-1 could be detected in the infarcted myocardium (Fig. 5.2 A; 
left panel). Also, by triple-labeling techniques, cells expressing CD31, Nkx2.5 and Isl-1 
were detected within the myocardium (Fig. 5.2 A; right panel). FACS analysis on single 
cell suspensions isolated from mouse hearts revealed that the majority of cardiac 
endothelial cells express Sca-1 (Fig. 5.2 B).  
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Figure 5.2: Endothelial cells express cardiac stem cell-associated genes. A IF stain with antibodies to cardiac stem cell-associated genes Nkx2.5 (blue in right panel) and Isl-1 (red) shows 
stem cell-associated gene expression in endothelial cells (green). B. FACS analysis was performed on single suspensions isolated from mouse hearts. Approximately 50% of all non- 
cardiomyocyte cardiac cells are endothelial cells that express stem cell antigen (Sca)-1; almost all endothelial cells express Sca-1.
65
Discussion 
Our data showing that mature endothelial cells are able to transform into myofibroblasts 
for cardiac repair in vivo and transition into spindle-shaped mesenchymal cells in vitro 
suggested that endothelial cells may have other stem cell characteristics. Consistent with 
this, in this chapter, we showed that endothelial cells proliferate at homeostasis in the 
healthy adult mouse heart as well as after injury and that endothelial cells express 
proteins that have been linked to cardiac stem/progenitor cells, specifically, Nkx2.5, Isl-1 
and Sca-1. 
 
These findings that endothelial cells display stem cell characteristics are in line with 
findings that other epithelial cells including cardiac epicardial cells display stem cell 
behavior and aid in cardiac wound healing after injury (Limana et al., 2007). Consistent 
with the notion that the endothelium/epithelium is an important stem cell source that 
undergoes mesenchymal transition to generate critical repair cells for wound healing, 
during development, epithelial-to-mesenchymal transition (EMT) serves as the source for 
almost all specialized cell types – EMT generates mesodermal cells from the primitive 
ectoderm (Nakaya and Sheng, 2008) and neural crest cells from the neuroepithelium 
(Sauka-Spengler and Bronner-Fraser, 2008) – also, later in development, distinct sets of 
cardiac progenitors that give rise to blood vessels and valves arise from epicardial EMT 
and endothelial EndMT (Winter and Gittenberger-de Groot, 2007; Armstrong and 
Bischoff, 2004). Adult repair mechanisms may therefore share a great deal with normal 
developmental processes that shape the cardiac tissue during embryogenesis 
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All together, our data support the notion that the endothelium is a cardiac stem cell and 
that canonical wnt signaling regulates its behavior. Interestingly, canonical wnt signaling 
has been shown to be an important regulatory mechanism in a number of cardiac 
stem/progenitor cell studies, including Isl-1-expressing cardiac stem cells (Lin et al., 
2007; Qyang et al., 2007), Mesp-1-expressing cardiac stem cells (Klaus et al., 2007) and 
mesenchymal stem cells (Mirotsou et al., 2007; Alfaro et al., 2008). Based on our 
findings that endothelial cells express a number of these genes, it will be interesting to 
know if these endogenous cardiac stem cells – i.e. endothelial cells and endothelial-
derived mesenchymal cells, Sca-1-expressing cells, Isl-1-expressing cells, Nkx2.5-
expressing cells, etc – are all really one and the same population of cells transitioning 
from one form to another, or distinct cardiac stem cell populations with unique functions. 
 
Methods 
Mice 
All procedures were carried out with the approval of the Institutional Animal Care and 
Use Committee of Vanderbilt University Medical Center.   
 
Experimental myocardial infarction 
The previously described protocol was followed 
 
Immunohistology 
The previously described protocol was followed. The primary antibodies used and their 
various dilutions were: Nkx2.5 (Santa Cruz; 1:50 dilution), Isl-1 (Abcam; 1:100 dilution), 
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CD31/PECAM (BD Pharmingen; 1:100 dilution), Smooth muscle actin (Sigma; 1:800 
dilution), Cardiac α−actinin (Sigma; 1:1,000 dilution) and Ki67 (Abcam; 1:500 dilution).  
 
FACS analysis 
Performed as previously described. Stem cell antigen (Sca)-1 was purchased from 
ebioscience and used at a 1:100 dilution 
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CHAPTER VI 
 
ATTEMPTS AT CANONICAL WNT PATHWAY MANIPULATION in vivo 
WERE UNSUCCESSFUL 
 
 
 
Introduction 
The data presented so far show that the canonical wnt signaling pathway is activated 
during the granulation tissue formation phase of the myocardial infarction response, that 
canonical wnt activation coincides with post-infarction endothelial-to-mesenchymal 
transition, and that canonical wnt signaling is sufficient to induce a mesenchymal 
transition in the mature vascular endothelium. Our data show that the endothelium is a 
versatile cell type that serves as a source of both new blood vessels and scar-forming 
myofibroblasts. 
 
Our studies suggest that canonical wnt signaling, by regulating endothelial cell behaviour 
and mediating EndMT during post-MI granulation tissue formation, contributes to both 
new blood vessel formation and fibrosis. Our studies also suggest that post-MI cardiac 
repair may be improved by temporal and cell type-specific manipulation of canonical wnt 
signaling.  
 
In initial attempts to test these hypotheses, TOPGAL mice were treated with recombinant 
protein and small molecule inhibitors of the canonical wnt pathway in order to 
manipulate post-MI canonical wnt activity and subsequent canonical wnt-mediated 
processes. 
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Results 
Dkk-1, at a dose of 500 μg/Kg of body weight, did not affect MI-induced canonical wnt 
activation, EndMT or cardiac function decline 
 
In order to assess the effect of canonical wnt pathway manipulation on post-infarction 
EndMT, angiogenesis and fibrosis, TOPGAL mice were treated with the canonical wnt 
inhibitor, Dkk-1 (500μg/Kg of body weight), or with vehicle (PBS), 3, 4, and 5 days after 
being subjected to LAD occlusion or sham surgeries. This dose of Dkk-1 has previously 
been reported to inhibit canonical wnt signaling activity in vivo (Aicher et al., 2008).  
 
Our results show that 500μg/Kg of body weight of Dkk-1 was insufficient to block 
myocardial infarction-induced canonical wnt activation, as shown by the lack of 
statistically significant differences between vehicle and Dkk-1 treated mice in the post-
MI expression of canonical wnt targets (Fig. 6.1 A). Consistent with its lack of effect on 
in vivo canonical wnt signaling, the given dose of Dkk-1 did not affect infarction-induced 
EndMT as assayed by RT-PCR for the expression of EndMT-associated genes and FACS 
analysis for the presence of cells doubly positive for CD31 and SMA (Fig. 6.1 B). 
Cardiac function, as assessed by echocardiography, did not vary significantly between 
vehicle and Dkk-1-treated animals (Fig. 6.1 C).  
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Figure 6.1: 500mg/Kg BW of Dkk-1 did not affect MI-induced canonical wnt activation, EndMT or cardiac 
function decline. Mice were subject to LAD occlusion or sham surgeries and treated with vehicle or Dkk.1. A. Effect 
on expression of canonical wnt targets and EndMT-related genes was tested by real-time quantitative RT-PCR. B. 
Effect on generation of cells co-expressing CD31 and SMA was tested by FACS analysis. C. Effect on cardiac function 
was tested by echocardiography. 
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Intraperitoneal injection of the small molecule canonical wnt inhibitor, IWR-1, did not 
affect canonical wnt signaling or EndMT in vivo likely because IWR-1 is rapidly cleared 
 
The high cost of Dkk-1 made it unfeasible to escalate the dose of Dkk-1 given to mice. 
Instead, we sought small molecule alternatives to recombinant proteins for in vivo 
experimentation with canonical wnt inhibition. IWR-1 is a small molecule compound 
which inhibits canonical wnt signaling by stabilizing Axin2 and thus enhancing the 
degradation of β−catenin (Chen et al., 2009). TOPGAL mice were treated with 3mg/Kg 
of body weight of IWR-1, twice a day, for three days. On the third day, mice were 
sacrificed, livers isolated and assayed for β−galactosidase activity using an optical 
density measurement system. The results show that the given doses of IWR-1 did not 
significantly affect baseline β−galactosidase activity (Fig. 6.2 A). The effect of IWR1 
treatment on MI-induced canonical wnt activation and EndMT was assessed by treating 
mice with vehicle (DMSO) or 3mg/Kg of body weight of IWR-1, 3, 4, and 5 days after 
being subjected to LAD occlusion or sham surgeries. The results show that the given 
IWR-1 drug regimen did not affect MI-induced up-regulation of the canonical wnt target, 
WISP1 or EndMT-associated gene, Snail (Fig 6.2 B). To assay the pharmacokinetic 
properties of IWR-1, plasma was isolated from mice 10 minutes, 3 hours and 24 hours 
after intraperitoneal injection of 3mg/Kg of body weight of IWR-1. Isolated plasma was 
subjected to mass spectrometric analysis. The results show that IWR-1 is rapidly cleared 
with 50-70% of the initial dose being detected after 10 minutes, 5-10% after 3 hours and 
0% after 24 hours (Fig. 6.2 C).  
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Figure 6.2: IP injection of IWR-1 did not affect canonical wnt signaling or EndMT in vivo likely because IWR-1 is 
rapidly cleared. A. TOPGAL mice were given five IP doses of DMSO or 3mg/Kg BW IWR-1 over the course of three days. 
Livers were isolated and assayed for beta-gal activity. B. Mice treated with DMSO or 3mg/Kg BW were subject to sham or 
LAD occlusion surgeries. Hearts were isolated and real-time quantitative PCR for the expression of canonical wnt targets and 
EndMT-associated genes was performed 7 days after surgery. C. IWR-1 clearance was measured by mass spectrometry on 
plasma isolated 10mins, 3hrs and 24hrs after IP injection of 3mg/Kg BW.  
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Discussion 
Our in vivo and in vitro data from previous chapters suggest that canonical wnt signaling 
mediates EndMT during post-MI granulation tissue formation and by so doing, likely 
contributes to both new blood vessel formation and fibrosis. In this chapter, attempts to 
manipulate canonical wnt signaling in vivo and thereby test the hypothesis that canonical 
wnt signaling activation is necessary for post-MI EndMT and subsequent 
neovascularization and fibrosis, fell short. Our experiments treating mice with 500 μg/Kg 
of body weight of the endogenous canonical wnt inhibitor, Dkk-1, showed no effect on in 
vivo canonical wnt signaling activity and as a result, no effect on post-MI EndMT or 
other cardiac parameters. Our experiments with Dkk-1 suggest that a higher dose of the 
protein, or a different delivery method, may be necessary to attenuate myocardial 
infarction-induced canonical wnt activation and EndMT, and subsequently affect post-MI 
cardiac function. 
 
The lack of success with Dkk-1 led us to seek alternatives to recombinant proteins for the 
post-infarction manipulation of canonical wnt signaling activity. We turned to the small 
molecule, IWR-1, which inhibits canonical wnt signaling activity by stabilizing Axin2 
and promoting the degradation of β−catenin. The data show that treating mice with IWR-
1 did not cause any measurable effect on canonical wnt signaling activity or EndMT. 
Mass spectrometric analysis of the pharmacokinetics of IWR-1 showed that the 
compound is rapidly cleared suggesting that if IWR-1 is to be used to attenuate canonical 
wnt signaling activity in vivo, continuous intravenous (IV) dosing may be necessary to 
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produce an effect on myocardial infarction-induced canonical wnt activation and 
endothelial-to-mesenchymal transition.  
 
In summary, our initial attempts at manipulating in vivo canonical wnt signaling via 
intraperitoneal injections of recombinant protein or small molecule wnt pathway 
inhibitors proved unsuccessful. The question of whether post-infarction 
neovascularization and fibrosis are altered by manipulation of canonical wnt signaling 
thereby remains open.   
 
Methods 
Mice 
All procedures were carried out with the approval of the Institutional Animal Care and 
Use Committee of Vanderbilt University Medical Center.   
 
Experimental myocardial infarction 
The previously described protocol was followed 
 
Echocardiography 
Performed as previously described 
 
FACS analysis 
Performed as previously described.  
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Mouse plasma isolation 
Mice were injected with 50 μl of 50 mg/ml heparin solution. Ten minutes after injection, 
mice were anesthetized and sacrificed. Blood was isolated from mouse hearts and spun 
for 7 minutes at 13,200rpm in order to obtain plasma, the top liquid layer. 
 
Mass spectrometry 
Isopropanol (500 μl) was added to mouse plasma (250 μl). The plasma solution was 
mixed by vortexing, and centrifuged at 18,000g for 5 minutes at 5oC. The clear 
supernatant was filtered, dehydrated under nitrogen and reconstituted in 20% acetonitrile 
solution. Plasma solution was then injected into LC/MS for mass spectrometric analysis. 
Mass spectrometric analyses were performed at the Vanderbilt University Mass 
Spectrometry Research Center.  
 
β-galactosidase activity optical density assay 
Measurement of β−galactosidase activity was performed using high sensitivity 
β−galactosidase assay kit (Agilent) according to the manufacturer’s protocol. Briefly, 
mouse livers were harvested and lysed in lysis buffer, containing Triton-X 100. Lysates 
were treated with chlorophenol red−β−D-galactopyranoside (CPRG), a substrate for 
β−galactosidase enzyme that turns from yellow-orange to red upon cleavage, and 
incubated at 37oC till reaction mixture turned dark red. Optical density was read at 595 
nm.  
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Quantitative RT-PCR analysis 
Total RNA was isolated from mouse hearts using the Trizol reagents (Invitrogen) 
following the manufacturers’ instructions. Reverse transcription of RNA into cDNA and 
quantitative PCR analysis were performed as previously described. Forward and reverse 
primer sequences are listed in Table 1. 
 
Statistical analysis 
The GraphPad Prism software was used to handle data.  Results are reported as mean + 
S.E.M.  Student’s t-test was used for comparing two groups.  
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CHAPTER VII 
 
SUMMARY AND CONCLUSIONS 
 
Summary 
Myocardial infarction is the leading cause of death worldwide.  Current available MI 
therapies, including thrombolytics and percutaneous coronary interventions, are aimed at 
opening the blocked coronary artery and preventing further ischemic injury to the heart. 
However, no therapies currently exist to repair already damaged cardiac tissue and as a 
result, heart failure is often a complication of myocardial ischemic injury. A better 
understanding of the cellular and molecular events that occur after ischemic heart injury 
may lead to the identification of new therapeutic targets that may ultimately result in 
myocardial repair. The fact that canonical wnt pathway intermediates are induced after 
MI suggests that the canonical wnt pathway may be a novel MI therapeutic target 
However, the effect of wnt pathway manipulation on post-MI wound healing and 
recovery has been controversial, with several studies yielding contradictory reports. As 
these contradictions may be due to ambiguities surrounding the activation state of the 
canonical wnt pathway after MI, the issue of whether the post-MI increase in wnt 
pathway intermediates leads to canonical wnt pathway activation, at what phase of the 
injury response such activation occurs, and what processes are mediated by activated 
canonical wnt signaling, was the focus of this dissertation project. 
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The experiments presented here use the canonical wnt reporter, TOPGAL transgenic 
mouse line, and RT-PCR for the expression of canonical wnt targets, to show that the 
canonical wnt signaling pathway is induced after myocardial infarction. The results show 
that post-MI canonical wnt activation occurs during granulation tissue formation, and 
coincides with endothelial-to-mesenchymal transition (EndMT). The data show that 
canonical wnt signaling is active in endothelial-derived myofibroblasts generated during 
granulation tissue formation. Furthermore, the experiments show that activation of the 
canonical wnt signaling pathway is sufficient to induce EndMT in cultured endothelial 
cells.  
 
Implications 
These findings show that canonical wnt activation and endothelial-to-mesenchymal 
transition are myocardial infarction responses that occur during granulation tissue 
formation. The study suggests that the canonical wnt signaling pathway may mediate 
EndMT after MI. Our findings are in support of a model postulating that activation of 
canonical wnt signaling in endothelial cells after ischemic injury leads to EndMT and 
generation of bipotential mesenchymal cells.  These migratory mesenchymal intermediate 
cells may then take part in neovascularization and myofibroblast generation, giving rise 
to new blood vessels and laying down collagen for subsequent scar formation (Fig. 7.1). 
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Figure 7.1: Model: The endothelium serves as a cardiac stem cell source. Our data show that endothelial 
cells are a versatile population of cells, capable of self-renewal and transformation into myofibroblasts 
when the need arises. Our data also show that the canonical wnt signaling pathway acts as a regulator of 
endothelial cell behavior; activation of canonical wnt signaling is able to induce EndMT in vitro. We 
propose a model whereby canonical wnt signaling initiates a mesenchymal transition in endothelial cells to 
yield a migratory intermediate cell population that gives rise to both new blood vessels and scar-forming 
myofibroblasts during post-MI granulation tissue formation. The expression of cardiac progenitor cell-
associated genes in endothelial and wnt-active cells raises the possibility that the endothelium may also 
give rise to cardiomyocytes. Teasing out the signals that push migratory mesenchymal intermediate cells to 
form cardiomyocytes and new blood vessels, instead of myofibroblasts, and vice versa, will be important 
for the development of new MI therapies. 
 
 
In support of our model, both endothelial-to-mesenchymal transition and canonical wnt 
signaling have been shown to contribute to angiogenesis and fibrosis in development and 
disease. EndMT has been shown to play a role in angiogenesis in the retina (Gerhardt et 
al., 2003), tumor angiogenesis (Potenta et al., 2008), and fibrosis in a number of chronic 
diseases (Zeisberg et al 2008; Hashimoto et al 2009; Zeisberg et al 2007; Widyantoro et 
al 2010)). Similarly, canonical wnt signaling has been shown to be important for proper 
vascular formation in the placenta (Monkely et al., 1996). The link between canonical 
New blood vessels 
Endothelium: CD31high
Myofibroblasts
CD31_ SMAhigh
Collagen 
??
Cardiomyocyte
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wnt signaling and angiogenesis is additionally supported by tumor studies which show 
that blocking wnt signaling inhibits angiogenesis (Hu et al 2009; Zhang et al 2010). 
Canonical wnt signaling has also been implicated in fibroproliferative diseases such as, 
fibromatoses, Dupuytren’s contracture and hypetrophic skin keloid scars (Bowley et al., 
2007), as well as in fibrosis during aging (Brack et al., 2007). Ours is the first to connect 
canonical wnt signaling to EndMT and subsequent angiogenesis and fibrosis in the 
healing myocardium.  
 
Our study implicates the endothelium as a major source of repair cells during granulation 
tissue formation. Our findings show that the endothelium not only reproduces itself, but 
also transforms into another cell type, the mesenchymal myofibroblast. Defined this way, 
as a cell that reproduces itself and differentiates into other cell types, the endothelium can 
be considered as a stem cell. Consistent with this notion, endothelial cells proliferate at 
homeostasis in the healthy adult mouse heart and also after ischemic injury. Furthermore, 
endothelial cells express the cardiac stem cell-associated genes, Nkx2.5, Isl-1 and Stem 
cell antigen (Sca)-1. 
 
In summary, our work shows an intricate cellular (EndMT) and molecular (canonical wnt 
signaling) connection between two critical repair mechanisms with apparently opposing 
effects, beneficial neovascularization and detrimental fibrosis.  Such a dynamic role may 
explain why studies manipulating the wnt pathway in experimental MI models 
occasionally yield contradictory results. 
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Limitations and Future directions 
The data presented show that the canonical wnt signaling pathway is activated during the 
granulation tissue formation phase of the myocardial infarction response, that canonical 
wnt activation coincides with post-infarction endothelial-to-mesenchymal transition, and 
that canonical wnt signaling is sufficient to induce a mesenchymal transition in the 
mature vascular endothelium.  
 
Our studies suggest that canonical wnt signaling mediates EndMT during granulation 
tissue formation after myocardial infarction, and by so doing, contributes to both new 
blood vessel formation and fibrosis. Our studies also suggest that post-MI cardiac repair 
may be improved by temporal and cell type-specific manipulation of canonical wnt 
signaling.  
 
Attempts to manipulate canonical wnt signaling in vivo and test these hypotheses via 
intraperitoneal injections of recombinant protein or small molecule wnt pathway 
inhibitors proved unsuccessful. Therefore, the issue of whether post-MI cardiac repair 
can be improved by temporal and cell type-specific manipulation of canonical wnt 
signaling still needs to be studied. Other than treatment with recombinant protein or small 
molecule canonical wnt inhibitors, the use of conditional inducible cre strategies to 
attenuate canonical wnt signaling activity during the period of granulation tissue 
formation may also help address the issue.  
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Finally, based on the technologies at our disposal, our study was limited to elucidating 
the post-MI role of the canonical wnt/β−catenin branch of the wnt signaling pathway. 
However, wnt pathway intermediates, such as Wnt-4 and Wnt-11, which have been 
implicated in non-canonical wnt signaling (Du et al., 1995; Pandur et al., 2002; Maurus et 
al., 2005; Chang et al., 2007), are also induced post-MI. In addition, dkk-1, which has 
been implicated in preferentially activating the non-canonical wnt branch while inhibiting 
the canonical/β−catenin branch (Semënov et al., 2001; Chien et al., 2009), is up-regulated 
after MI. Therefore, elucidating the post-MI interactions between the canonical and non-
canonical branches of the wnt signaling pathway may help further knowledge to improve 
the course of cardiac recovery.  
 
Conclusions 
In conclusion, this dissertation project sought to understand the role the canonical wnt 
signaling pathway plays in the myocardial infarction response. Our work showed that 
canonical wnt signaling is induced in the healing (granulation tissue formation) stages of 
myocardial infarction. We identified endothelial-to-mesenchymal transition as a cellular 
response to MI that occurs during granulation tissue formation, coincident with canonical 
wnt activation. Furthermore, we show that canonical wnt signaling is sufficient to induce 
endothelial-to-mesenchymal transition in the mature vasculature. Our findings suggest 
that the granulation tissue formation stage is a target for potential therapies to modulate 
canonical wnt signaling and EndMT. Our studies also suggest that canonical wnt and 
EndMT-modulating therapies may affect both beneficial neovascularization and 
detrimental fibrosis. Future studies elucidating the signals that cue endothelial-derived 
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mesenchymal cells to form new blood vessels rather than myofibroblasts and vice versa 
will be important for the generation of novel MI therapies. 
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Table 1. Sequence of primers used for PCR amplification
Mouse Primers
Gene Forward primer Reverse primer
Col1A1** ATGGATTCCCGTTCGAGTACG TCAGCTGGATAGCGACATCG
c-Myc CAAATCCTGTACCTCGTCCGATTC AGCTGGATAGTCCTTCCTTGTGGAG
Dkk-1 CAACTACCAGCCCTACCCTTGCG CAGACGGAGCCTTCTTGTCCTTTG
Dkk-2 ATGAACCAAGGACTGGCTTTCGG CGAGCACAACAAAACCCATCAATG
Dkk-3 GCCTCAGATGACGGTTTCAGGTGC GCTGTGCTGCCTCTCCTTAGTTTCAAC
FSP1** TCAGGCAAAGAGGGTGACAAG AGGCAGCTCCCTGGTCAGT
Snail GATGAGGACAGTGGCAAAAGCTC AGAATGGCTTCTCACCAGTGTGG
TCF7 ATCCACCACAGGAGGAAAAAGAAAT GTTAGGCTGCCTGTCTCTGAGATTC
TGFβ1 AGATTAAAATCAAGTGTGGAGCAAC GTCCTTCCTAAAGTCAATGTACAGC
Vimentin GGTACAAGTCCAAGTTTGCTGACCT CATTGAGCAGATCTTGGTATTCACG
WISP1 CAGATGGCTGTGAATGCTGTAAGAT GGATGCAACACCTATTGTCAGTACA
Wnt-1 AGTCCTGCACCTGCGACTAC CCTCGGTTGCCGTAAAGGAC
Wnt-2 ACTTCAGGAAAACAGGCGACTATC AATTTACACTCACACTTGGTCATCC
Wnt-2b GACTACCTGAGGAGGCGATATG CATCCACAGTGTTTCTGCACTC
Wnt-3 GGAGAAACGGAAGGAGAAATG GAGAGACGTTAGTTGAGAAAGAAGC
Wnt-3a GAGGGATCAGCTGCTATCTGTG GTCATACTTGTCCTTGAGGAAATC
Wnt-4 AGCAGGTGTGGCCTTTGCAGTGAC CGTTGTTGTGAAGATTCATGAGTGCC
Wnt-5a GAGACAACATCGACTATGGCTACC GTTGACCTGCACCAGCTTGC
Wnt-5b CAGAGAGGGTGAGCTGTCCAC CTGTCGTACTTCTCCTTCAAACG
Wnt-6 CAACTGGCTCTCCAGATGCT AGAGCTTTGCCGTCGTTGGT
Wnt-7a GAAGGAGCTCAAAGTGGGTATTC CTTACACTCCAGCTTCATGTTCTC
Wnt-7b AGTGGATCTTTTACGTGTTTCTCTG CTGGTTGTAGTAGCCTTGCTTCTC
Wnt-8a CTGCAGCGACAACGTGGAGT GCTCTGTTGCCAGCCCTTAG
Wnt-8b AGAATGTAAATACCAGTTTGCTTGG CATTGTTGTGCAGATTCATGG
Wnt-9a AAGTACAGCAGCAAGTTTGTCAAG CCACCTCCTGACCCAGAAGC
Wnt-9b CGCTGTACTTGTGACGACTCC GTGTCATAGCGTAGCTTCAGC
Wnt-10a AGAACGCTTCTCTAAGGACTTTCTG AGTCGGGAGATTTCTCAAAGTAGAC
Wnt-10b AGAAGTTCTCTCGGGATTTCTTG CAAAGTAAACCAGCTCTCCAG
Wnt-11 GCTACCTGTCAGCCACGAAGGTG CTGCCGTTGGAAGTCTTGTTGCAC
** Reference: Zeisberg et al., 2007
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Table 1, continued
Bovine Primers
Gene Forward primer Reverse primer
Axin2 CGAGCTGGTGGTCACTTACTTCTTC AGGGCTCAGTCGATCCTCTCC
CD31 GAATGTAGCAATTCATCAGGCCAAG ACTAGCCCCTAAGCTAGGCCACTCT
Col1A1 CTCTGACTGGAAGAGCGGAGAATAC CTGTTCTTGCAGTGGTAGGTGATGT
SMA CAGGAAGGACCTCTATGCTAACAACG GACAGACAAGAGAGCAGGGAGTGTC
Slug TCCACCTCTGAGCGACAAGTAAAAG TTACAAATCCCGTACAAGGCAACAC
TCF7 CCCTGACCTCTCTGGCTTCTACTCT CAATGACTTTGGCTCTCATCTCCTT
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